Bisoprolol, marketed under the brand name Zebeta. Introduced to the market in 1992, Zebeta is primarily prescribed for managing high blood pressure (hypertension) and for treating chronic heart failure. As a selective beta-1 adrenergic blocker, Zebeta works by reducing heart rate and decreasing the force of heart contractions, which helps lower blood pressure and alleviate heart strain. This medication is typically administered in tablet form once daily. Known for its effectiveness and relatively favorable side effect profile, Zebeta is an important option for patients with cardiovascular conditions. Patients should follow their prescribed regimen and consult their healthcare provider regularly to ensure optimal management of their condition and to monitor for any potential side effects.
